Healthcare provider profile · identity verified

John Joseph Travers, MD

Family Practice · WYOMISSING, PA · NPI 1811997851

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	586	157
Levothyroxine Sodium	Levothyroxine Sodium	413	114
Rosuvastatin Calcium	Rosuvastatin Calcium	406	116
Simvastatin	Simvastatin	321	87
Amlodipine Besylate	Amlodipine Besylate	317	92
Omeprazole	Omeprazole	284	91
Lisinopril	Lisinopril	241	73
Metoprolol Succinate	Metoprolol Succinate	222	67
Metformin Hcl	Metformin Hcl	195	57
Hydrochlorothiazide	Hydrochlorothiazide	184	51
Montelukast Sodium	Montelukast Sodium	181	51
Pantoprazole Sodium	Pantoprazole Sodium	180	51
Valsartan	Valsartan	176	47
Escitalopram Oxalate	Escitalopram Oxalate	174	48
Gabapentin	Gabapentin	171	46
Tamsulosin Hcl	Tamsulosin Hcl	165	49
Eliquis	Apixaban	158	31
Losartan Potassium	Losartan Potassium	152	45
Metoprolol Tartrate	Metoprolol Tartrate	149	50
Alprazolam	Alprazolam	147	41
Furosemide	Furosemide	137	48
Lorazepam	Lorazepam	113	29
Synthroid	Levothyroxine Sodium	112	32
Albuterol Sulfate Hfa	Albuterol Sulfate	100	44
Atenolol	Atenolol	99	25
Pravastatin Sodium	Pravastatin Sodium	94	27
Tramadol Hcl	Tramadol Hcl	94	22
Metformin Hcl Er	Metformin Hcl	91	29
Zolpidem Tartrate	Zolpidem Tartrate	91	19
Jardiance	Empagliflozin	90	24
Potassium Chloride	Potassium Chloride	88	28
Clonazepam	Clonazepam	79	16
Bupropion Xl	Bupropion Hcl	75	16
Allopurinol	Allopurinol	74	25
Carvedilol	Carvedilol	70	16
Trazodone Hcl	Trazodone Hcl	67	19
Fluticasone Propionate	Fluticasone Propionate	66	27
Ramipril	Ramipril	66	17
Famotidine	Famotidine	63	16
Citalopram Hbr	Citalopram Hydrobromide	60	14
Sertraline Hcl	Sertraline Hcl	57	18
Ezetimibe	Ezetimibe	56	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	11
Spironolactone	Spironolactone	55	14
Cephalexin	Cephalexin	50	25
Duloxetine Hcl	Duloxetine Hcl	50	14
Buspirone Hcl	Buspirone Hcl	48	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	48	12
Meloxicam	Meloxicam	47	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	13
Prednisone	Prednisone	44	27
Glimepiride	Glimepiride	43	13
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Azelastine Hcl	Azelastine Hcl	39	16
Januvia	Sitagliptin Phosphate	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	18
Klor-Con M20	Potassium Chloride	37	14
Valacyclovir	Valacyclovir Hcl	37	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	28
Azithromycin	Azithromycin	36	26
Doxycycline Hyclate	Doxycycline Hyclate	36	35
Hydralazine Hcl	Hydralazine Hcl	36	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	36	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	suppressed
Xarelto	Rivaroxaban	36	11
Morphine Sulfate Er	Morphine Sulfate	35	suppressed
Telmisartan	Telmisartan	35	suppressed
Terazosin Hcl	Terazosin Hcl	33	suppressed
Amoxicillin	Amoxicillin	31	20
Bisoprolol Fumarate	Bisoprolol Fumarate	31	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	12
Propranolol Hcl	Propranolol Hcl	31	suppressed
Finasteride	Finasteride	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Meclizine Hcl	Meclizine Hcl	28	11
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Myrbetriq	Mirabegron	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	24	suppressed
Dexamethasone	Dexamethasone	24	21
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Nitroglycerin	Nitroglycerin	22	15
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Mupirocin	Mupirocin	21	12
Topiramate	Topiramate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Fentanyl	Fentanyl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Ondansetron Odt	Ondansetron	19	15
Triamcinolone Acetonide	Triamcinolone Acetonide	19	15
Methylprednisolone	Methylprednisolone	18	15
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Temazepam	Temazepam	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Lovastatin	Lovastatin	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ozempic	Semaglutide	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Estradiol	Estradiol	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Glipizide	Glipizide	12	suppressed
Invokana	Canagliflozin	12	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error